Phase 1 10 trials
Phase 1
NCT03896750 Apr → Aug 2024 impaired renal function disease , tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1
NCT05586230 Oct 2023 → Apr 2026 rifampicin-resistant tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1
NCT04309656 Jan → Feb 2020 multidrug-resistant tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 1
NCT02422524 Mar 2018 → Aug 2023 tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Terminated
No outcome recorded
Phase 1
NCT01674218 Sep → Dec 2012 tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1
NCT01571414 May 2012 → May 2013 tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1
NCT01768273 Dec 2009 → Jan 2010 tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 1
NCT01830439 Sep 2009 → Jan 2010 tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 1
NCT01828827 Mar 2007 tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 1
NCT03202693 Mar → May 2006 tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2 16 trials
Phase 2
NCT07227779 Jul 2026 → Aug 2030 expected meningeal tuberculosis University of Minnesota
Not yet recruiting
No outcome recorded
Phase 2
NCT07672405 Jul 2026 → May 2027 expected pulmonary tuberculosis Global Alliance for TB Drug Development
Recruiting
No outcome recorded
Phase 2
NCT06192160 Mar 2025 → Nov 2026 expected pulmonary tuberculosis National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
No outcome recorded
Phase 2
NCT06114628 Jan 2024 → Feb 2027 expected pulmonary tuberculosis University College, London
Recruiting
No outcome recorded
Phase 2
NCT06058299 Oct 2023 → Dec 2024 overdue pulmonary tuberculosis Global Alliance for TB Drug Development
Active not recruiting
No outcome recorded
Phase 2
NCT05971602 Jul 2023 → Feb 2025 pulmonary tuberculosis Gates Medical Research Institute
Terminated
No outcome recorded
Phase 2
NCT05807399 Apr 2023 → Oct 2027 expected pulmonary tuberculosis Michael Hoelscher
Recruiting
No outcome recorded
Phase 2
NCT05382312 Jul 2022 → May 2025 tuberculosis GlaxoSmithKline
Completed
No outcome recorded
Phase 2
NCT04179500 Sep 2021 → Jun 2023 multidrug-resistant tuberculosis , pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT02256696 Apr 2015 → May 2022 pulmonary tuberculosis Johns Hopkins University
Completed
No outcome recorded
Phase 2
NCT02193776 Oct 2014 → Feb 2016 tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT01691534 Oct 2012 → Apr 2013 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT01498419 Mar 2012 → Apr 2013 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT01215851 Oct 2010 → May 2011 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT00944021 Aug 2009 → Jan 2010 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2
NCT00567840 Aug → Dec 2007 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Show 6 more trials Phase 2/3 6 trials
Phase 2/3
NCT06441006 Oct 2025 → Aug 2031 expected multidrug-resistant tuberculosis , pulmonary tuberculosis University of California, San Francisco
Recruiting
No outcome recorded
Phase 2/3
NCT05686356 Jul 2023 → Jan 2026 overdue tuberculosis The Aurum Institute NPC
Active not recruiting
No outcome recorded
Phase 2/3
NCT04207112 Oct 2020 → Aug 2022 extensively drug-resistant tuberculosis , multidrug-resistant tuberculosis , pulmonary tuberculosis Medecins Sans Frontieres, Netherlands
Completed
No outcome recorded
Phase 2/3
NCT04081077 Aug 2019 → Sep 2022 extensively drug-resistant tuberculosis , multidrug-resistant tuberculosis , pulmonary tuberculosis Medecins Sans Frontieres, Netherlands
Unknown
No outcome recorded
Phase 2/3
NCT03338621 Jul 2018 → Jul 2021 multidrug-resistant tuberculosis , pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 2/3
NCT02589782 Jan 2017 → Aug 2022 extensively drug-resistant tuberculosis , multidrug-resistant tuberculosis , pulmonary tuberculosis Medecins Sans Frontieres, Netherlands
Completed
No outcome recorded
Phase 3 4 trials
Phase 3
NCT07209761 Oct 2025 → May 2027 expected pulmonary tuberculosis Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting
No outcome recorded
Phase 3
NCT03086486 Nov 2017 → Feb 2021 extensively drug-resistant tuberculosis , multidrug-resistant tuberculosis , pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 3
NCT02333799 Mar 2015 → Jan 2019 pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 3
NCT02342886 Feb 2015 → Jan 2018 multidrug-resistant tuberculosis , pulmonary tuberculosis Global Alliance for TB Drug Development
Completed
No outcome recorded
Phase 4 2 trials
Phase 4
NCT05381194 Dec 2022 → Dec 2027 expected multidrug-resistant tuberculosis Asan Medical Center
Recruiting
No outcome recorded
Phase 4
NCT03237182 Jun 2017 → Dec 2022 multidrug-resistant tuberculosis Centre for the AIDS Programme of Research in South Africa
Terminated
No outcome recorded
Phase not applicable 1 trial
— NCT07126639 Sep 2025 → Sep 2027 expected —
Wuhan Pulmonary Hospital
Not yet recruiting
No outcome recorded